Ovodan Biotech A/S develops high-affinity antibodies for scientific biotech research and medical diagnostic industries. Based on a unique one-step purification technology Ovodan Biotech provides the market with ready-to-use polyclonal antibodies targeted toward a range of catalogue biomarkers and custom-made targets.

Since 2011 Ovodan Biotech has served the market with high-quality chicken antibodies (IgY) purified from egg yolk. Immunization of chickens offers a less stressful and a non-invasive method as known from mammal immunization. It only requires daily collection of eggs, where the yolks contain the valuable antibodies.

To ensure a high-quality result, Ovodan Biotech has developed a state-of-the-art technology that offers affinity-purified chicken antibody (IgY), where more than 99% of the antibodies being highly antigen-specific. Furthermore, the process is efficient and optimized for bulk production.

Ovodan Biotech continuously strives to maintain a catalogue of antibodies toward relevant targets. Therefore, intensive collaboration with international acknowledged scientists and universities are important to the R&D department.

In addition to the catalogue antibodies, Ovodan Biotech offers contract immunization for specific targets for science research and diagnostics.

Headquarters

OVODAN BIOTECH A/S
Havnegade 36
DK-5000 Odense C

Denmark

Tel +45 6611 1732

hpe@ovodan.com

www.ovodanbiotech.com